Lyell Immunopharma Statistics
Total Valuation
LYEL has a market cap or net worth of $522.79 million. The enterprise value is $326.56 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LYEL has 23.33 million shares outstanding. The number of shares has increased by 30.74% in one year.
| Current Share Class | 23.33M |
| Shares Outstanding | 23.33M |
| Shares Change (YoY) | +30.74% |
| Shares Change (QoQ) | +12.31% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 37.07% |
| Float | 13.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14,521.92 |
| Forward PS | 29,121.50 |
| PB Ratio | 1.92 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9,071.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.21.
| Current Ratio | 5.28 |
| Quick Ratio | 5.00 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -86.98% and return on invested capital (ROIC) is -33.45%.
| Return on Equity (ROE) | -86.98% |
| Return on Assets (ROA) | -29.83% |
| Return on Invested Capital (ROIC) | -33.45% |
| Return on Capital Employed (ROCE) | -68.22% |
| Weighted Average Cost of Capital (WACC) | 3.54% |
| Revenue Per Employee | $120 |
| Profits Per Employee | -$914,827 |
| Employee Count | 300 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +134.41% in the last 52 weeks. The beta is -0.07, so LYEL's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | +134.41% |
| 50-Day Moving Average | 22.64 |
| 200-Day Moving Average | 19.63 |
| Relative Strength Index (RSI) | 47.81 |
| Average Volume (20 Days) | 91,086 |
Short Selling Information
The latest short interest is 1.14 million, so 4.88% of the outstanding shares have been sold short.
| Short Interest | 1.14M |
| Short Previous Month | 940,269 |
| Short % of Shares Out | 4.88% |
| Short % of Float | 8.17% |
| Short Ratio (days to cover) | 11.52 |
Income Statement
In the last 12 months, LYEL had revenue of $36,000 and -$274.45 million in losses. Loss per share was -$16.06.
| Revenue | 36,000 |
| Gross Profit | 36,000 |
| Operating Income | -198.29M |
| Pretax Income | -274.45M |
| Net Income | -274.45M |
| EBITDA | -186.75M |
| EBIT | -198.29M |
| Loss Per Share | -$16.06 |
Full Income StatementBalance Sheet
The company has $247.22 million in cash and $50.99 million in debt, with a net cash position of $196.23 million or $8.41 per share.
| Cash & Cash Equivalents | 247.22M |
| Total Debt | 50.99M |
| Net Cash | 196.23M |
| Net Cash Per Share | $8.41 |
| Equity (Book Value) | 248.20M |
| Book Value Per Share | 11.68 |
| Working Capital | 211.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$150.02 million and capital expenditures -$780,000, giving a free cash flow of -$150.80 million.
| Operating Cash Flow | -150.02M |
| Capital Expenditures | -780,000 |
| Depreciation & Amortization | 11.54M |
| Net Borrowing | n/a |
| Free Cash Flow | -150.80M |
| FCF Per Share | -$6.46 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -550,791.67% |
| Pretax Margin | -762,355.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.74% |
| Shareholder Yield | -30.74% |
| Earnings Yield | -52.50% |
| FCF Yield | -28.85% |
Analyst Forecast
The average price target for LYEL is $30.60, which is 36.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.60 |
| Price Target Difference | 36.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 264.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
LYEL has an Altman Z-Score of -6.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.25 |
| Piotroski F-Score | 1 |
